Indicated for: spasticity; muscle spasms
Route of administration: oral
Substance: tizanidine (muscle relaxant)
ATC: M03BX02 (Musculo-skeletal system | Muscle relaxants, centrally acting agents | Other centrally acting agents)
Tizanidine is a muscle relaxant used in the treatment of spasticity associated with neurological conditions such as multiple sclerosis, spinal cord injuries, or strokes. It works by inhibiting the release of excitatory amino acids in the spinal cord, reducing increased muscle tone and spasms.
Tizanidine is administered orally, usually 2-3 times daily, with the dose gradually adjusted to minimize the risk of side effects. It is important for patients to follow the recommended dosage and avoid abrupt discontinuation of treatment, as this may lead to withdrawal symptoms.
Common side effects include drowsiness, dizziness, dry mouth, and muscle weakness. In rare cases, severe adverse reactions such as liver function impairment or hypotension may occur. Regular monitoring of liver function is essential during treatment.
Tizanidine is an effective therapeutic option for managing spasticity, contributing to improved mobility and quality of life for patients.